Skip to content
by Legal Desire
SIGN IN GO PRO
Lawyer profile

Peter Handrinos

Latham & Watkins LLP
Claim this profile
Firm
Latham & Watkins LLP
Practice
capital markets, Capital Markets, corporate
Office
Boston
Active in the record
2020 to 2026

Deal experience

Deal types
Banking & FinanceCapital Markets & IPOJoint VentureM&AVenture Capital & Growth
Sectors
Financial ServicesHealthcare & Life SciencesTechnology
Jurisdictions
AfricaCayman IslandsEuropeIndiaIrelandMassachusettsMiddle EastSoutheast AsiaUnited KingdomUnited States

Recent deals

19 announced deals in the record
Latham & Watkins Advises Pelthos Therapeutics in Combination With Castle Creek Biosciences 3 Nov 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 300m capital markets Boston
Latham Advises on TRexBio’s US$116.7 Million Initial Public Offering 12 Oct 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 117m Lead Capital Markets
Latham Advises on Kardigan’s US$460 Million IPO 30 Jun 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 460m Lead Capital Markets
Latham & Watkins Advises Remix Therapeutics in Merger With Passage Bio 30 Jun 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP Lead corporate
Latham & Watkins Advises Metsera in Strategic Collaboration With Amneal 3 Oct 2024
Joint Venture Healthcare & Life Sciences Latham & Watkins LLP corporate
Latham & Watkins Advises Seres Therapeutics in VOWST Asset Purchase Agreement With Nestlé Health Science 7 Aug 2024
M&A Healthcare & Life Sciences Latham & Watkins LLP Lead corporate
Latham Advises Rhythm on Agreement to Acquire Global Rights to Oral MC4R Agonist LB54640 From LG Chem 8 Jan 2024
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP Lead corporate
Latham & Watkins Advises Homology Medicines in Merger Agreement With Q32 Bio 28 Dec 2023
M&A Healthcare & Life Sciences Latham & Watkins LLP Lead corporate
Latham & Watkins Advises on Intellia Therapeutics’ Public Offering of Common Stock 2 Dec 2022
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 300m Lead capital markets
Latham & Watkins Advises on POINT Biopharma’s Common Stock Offering 15 Sept 2022
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 125m Lead corporate
Free account

6 more recent deals

Create a free account to see every deal team member, full deal lists on firm and lawyer pages, and to claim your profile.

REGISTER FREE SIGN IN
Deal alerts PRO

Get an email when Peter Handrinos is named on a newly announced deal.

See Pro plans

Alerts come as one daily email at most.

Free account

Register free to unlock

  • Every lawyer on every deal team, not just the first three
  • The full recent-deal list on lawyer pages
  • Claim and edit your own firm or lawyer profile
  • Submit deals and corrections
  • Request a Pro trial for your team
REGISTER FREE Sign in

You have a free account. Everything in this column is open to you.

Pro

Get Pro to see all 19 deals for Peter Handrinos

  • Complete deal history with keyword, type, sector and year filters
  • Frequent co-counsel and the firms most often on the other side
  • Repeat clients, as named in the announcements
  • Market share and deals by year, sector and deal type
  • Deal alerts by firm, lawyer, sector, deal type or jurisdiction
  • CSV and Excel export, up to 1,000 rows a day, and custom reports
GET PRO How Pro works
Is this you?

Claim your profile to add your title, a biography and a photo, and show a verified badge. It is free.

Claim this profile

Suggest a correction